Results 151 to 160 of about 59,883 (231)

Targeting Survivin: Now I Become Death, the Destroyer of Cells. [PDF]

Int J Mol Sci
Fanuzzi M, Zheng S, Horbinski CM, Shaaban MA, Congivaram H, Du R, Tripathi S, Hurley L, Kumthekar P, Ahmed A, Brat DJ, Lesniak MS, Heimberger AB.   +12 more
europepmc   +1 more source

Pleiotropic Effects of 3-<i>O</i>-Decanoylquercetin on U373-MG Human Glioma Cell Line. [PDF]

Int J Mol Sci
Dell'Albani P, La Cognata V, Torrisi SA, De Gaetano A, Foti MC.   +4 more
europepmc   +1 more source

Restoring apoptosis in breast cancer via peptide mediated disruption of survivin IAP interaction. [PDF]

Sci Rep
Taghavifar SM, Sabbaghfarshi S, Samadikhah H, Tackallou SH, Ahmadi SF.   +4 more
europepmc   +1 more source

[Retracted] Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression. [PDF]

Oncol Lett
Zhong F, Yang J, Tong ZT, Chen LL, Fan LL, Wang F, Zha XL, Li J.   +7 more
europepmc   +1 more source

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells [PDF]

, 2017
et al,, Ghasemi, Reza
core   +2 more sources

YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer. [PDF]

Pharmaceuticals (Basel)
Ruiz de Porras V, Bakht MK, Fernandez-Saorín M, Alcon C, Palomero L, Francisco-Rodon J, Figols M, Montero J, Conteduca V, Beltran H, Font A.   +10 more
europepmc   +1 more source

Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma. [PDF]

Exp Mol Med
Cazzanelli G, Dalle Vedove A, Broso F, Burigotto M, Zasso J, Aiello G, Zonta F, Astolfi A, Barreca ML, Ruzzene M, Tiberi L, Fava LL, Quattrone A, Lolli G.   +13 more
europepmc   +1 more source

Erratum: Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma. [PDF]

Am J Cancer Res
Bu LL, Deng WW, Huang CF, Liu B, Zhang WF, Sun ZJ.   +5 more
europepmc   +1 more source

Anti-HPV gel versus interferon α-2b gel as adjuvant therapy after LEEP for HSIL with HR-HPV infection on clinical outcomes, vaginal microecology, and biomarkers of proliferation and immunity. [PDF]

Front Oncol
Long X, Luo M, Yang C, Yan F, Pu H, Li X.   +5 more
europepmc   +1 more source

Fedratinib reveals chemotherapeutic potential in esophageal squamous cell cancer. [PDF]

Front Pharmacol
Luo M, Zhu J, Yang Y, Liao C, Liu X, Tang M, Xu L, Zhong X, Ma Q, Guo X.   +9 more
europepmc   +1 more source